These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 9653911

  • 21. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.
    Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto F, Modesti M, Quaglino D.
    Am J Hematol; 2001 Jun; 67(2):63-72. PubMed ID: 11343377
    [Abstract] [Full Text] [Related]

  • 22. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
    Bisset LR, Lung TL, Kaelin M, Ludwig E, Dubs RW.
    Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
    [Abstract] [Full Text] [Related]

  • 23. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J, Babusíková O.
    Neoplasma; 2004 Mar; 51(2):97-102. PubMed ID: 15190418
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
    Kooy AJ, Prens EP, Van Heukelum A, Vuzevski VD, Van Joost T, Tank B.
    J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
    [Abstract] [Full Text] [Related]

  • 27. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
    Yazawa T, Kamma H, Fujiwara M, Matsui M, Horiguchi H, Satoh H, Fujimoto M, Yokoyama K, Ogata T.
    J Pathol; 1999 Jan; 187(2):191-9. PubMed ID: 10365094
    [Abstract] [Full Text] [Related]

  • 28. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
    Ogino T, Bandoh N, Hayashi T, Miyokawa N, Harabuchi Y, Ferrone S.
    Clin Cancer Res; 2003 Sep 15; 9(11):4043-51. PubMed ID: 14519625
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications.
    Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M.
    Oncol Rep; 2003 Sep 15; 10(2):321-5. PubMed ID: 12579266
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer.
    Krecicki T, Jeleń M, Zalesska-Krecicka M, Rak J, Szajowski K.
    Acta Otorhinolaryngol Belg; 1998 Sep 15; 52(3):215-21. PubMed ID: 9810456
    [Abstract] [Full Text] [Related]

  • 32. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.
    Esteban F, Ruiz-Cabello F, Concha A, Pérez-Ayala M, Sánchez-Rozas JA, Garrido F.
    Clin Exp Metastasis; 1990 Sep 15; 8(4):319-28. PubMed ID: 2350918
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.
    Danilewicz M, Sikorska B, Wagrowska-Danilewicz M.
    Med Sci Monit; 2003 Mar 15; 9(3):MT42-7. PubMed ID: 12640351
    [Abstract] [Full Text] [Related]

  • 34. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T, Aokage K, Saijo N, Nishiwaki Y, Gemma A, Kudoh S, Ochiai A.
    Cancer; 2008 Sep 15; 113(6):1387-95. PubMed ID: 18671239
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer.
    Wolf GT, Bradford CR, Urba S, Smith A, Eisbruch A, Chepeha DB, Teknos TN, Worden F, Dawson L, Terrell JE, Hogikyan ND.
    Laryngoscope; 2002 Aug 15; 112(8 Pt 1):1351-6. PubMed ID: 12172244
    [Abstract] [Full Text] [Related]

  • 39. Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.
    Oldford SA, Robb JD, Codner D, Gadag V, Watson PH, Drover S.
    Int Immunol; 2006 Nov 15; 18(11):1591-602. PubMed ID: 16987935
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.